Abstract

To further substantiate the role of inter-organizational networking in innovation, we explored the positive impact of large networks on innovation in the biotechnology industry. The research was conducted in two parts. In the first part, a qualitative research methodology using exploratory case study is performed on the three SME members of the UK-based biotech network One Nucleus. In the second part, a quantitative research approach using comparative empirical OECD data analysis is performed. The two research methodologies used are subsequently linked together thorough a unique research approach known as processual research. A new insight is explored regarding issues linked to inter-organizational networking, like the role of networks on organizational learning, the role of third party organizations within networks, diversity of partners and the nature of learning (localized vs. global) within biotech networks. The primary data is generated on the number of alliances, types of alliances and types of innovation, whereas innovation is measured as a dependent variable. Empirical results obtained clearly indicate that innovation output (patent approval rate, patent success rate) with respect to each alliance made by the sample firms is positively impacted by the parent biotech network One Nucleus.

Highlights

  • Biotechnology is a multi-billion global industry; it encompasses several sectors or fields of applications, with several different research technologies or innovations

  • This study explores the impact of inter-organizational networking on innovation

  • The limitations of this research are two-fold: first, this research fails to develop some conceptual theoretical framework or innovation model that can be said to be applicable to the complex biotechnology industry

Read more

Summary

Introduction

Biotechnology is a multi-billion global industry; it encompasses several sectors or fields of applications, with several different research technologies or innovations. Innovation is indispensable for economic growth (Schumpter, 1934); it is not surprising that in highly technology-based industries like biotechnology, innovation is regarded as a mantra of success. Biotechnology has revolutionized the conventional knowledge of the pharmaceutical industry with new discoveries in novel areas like drug delivery, molecular genetics, immunology and cell biology (Gans and Stern, 2004). Powell, Koput and Doerr (1996) argued that the knowledge base. Journal of Technology Management for Growing Economies Vol 3 No 2.

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.